Galderma R&D implements ELN
Agilent Technologies has announced that Swiss pharmaceutical firm Galderma R&D has adopted the Agilent ELN to automate its scientific data management at its main R&D centre, the largest facility of its type devoted to dermatological research and development.
'We involved our end users in demonstration sessions based on our work-flow for chemistry,' said Catherine Parigot, project leader of Galderma R&D information management department in Sophia-Antipolis, France. After comparison with the leading solutions on the market, the user choice of Agilent ELN was unanimous. This was based largely on the ergonomics of the interface and the intuitive navigation through the different functions. Agilent was also able to demonstrate integration with existing information systems, such as our SDMS and our molecular registration system.'
Agilent claims that its ELN provides numerous benefits beyond eliminating paper lab notebooks. The open architecture is designed to simplify and accelerate the R&D process by streamlining data capture, speeding data search and retrieval, and eliminating redundant data entry. The system facilitates cross-team collaboration and easily integrates with existing processes and procedures. Agilent ELN contains safeguards for intellectual property and maintains record traceability.